anonymous
Guest
anonymous
Guest
This will be a horse race to see who’s more incompetent. Anyone that knows Eisai gets that it’s a complete shitshow there.
Biogen insists Eisai relationship 'solid' as questions remain over lecanemab commercialization | Fierce Biotech
Biogen insists Eisai relationship 'solid' as questions remain over lecanemab commercialization
Biogen insists Eisai relationship 'solid' as questions remain over lecanemab commercialization | Fierce Biotech
Biogen insists Eisai relationship 'solid' as questions remain over lecanemab commercialization